In a prospective pilot study, we investigated whether the combination of Skindex-291,2 and Functional Assessment of Cancer Therapy–General scale (FACT-G)1,3 provided relevant information during therapy on health-related quality of life (HRQOL) that would not be obtained from clinical assessment of patients with mycosis fungoides and/or Sézary syndrome (MF/SS).
Demierre M, Ferzli P, Miller D. Measuring HRQOL in Patients With Cutaneous T-Cell Lymphoma Undergoing Therapy With Oral Bexarotene and Extracorporeal Photopheresis. Arch Dermatol. 2007;143(5):659–675. doi:10.1001/archderm.143.5.659
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.